• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Avacta data at AACR 2026 underline favorable profile of AVA6103

    GLOBENEWSWIRE

    Avacta CEO Christina Coughlin Named In Vivo 2026 Rising Leader

    GLOBENEWSWIRE

    Avacta Treats First Patient in Phase 1 FOCUS-01 FAP-Exd Trial

    GLOBENEWSWIRE

    Avacta Presents Pre|Cision Candidates At 2026 AACR Conference

    GLOBENEWSWIRE

    Avacta Reveals Dual Clinical Advancements In Faridoxorubicin

    GLOBENEWSWIRE

    FDA Clears Avacta`s IND Application for AVA6103 (FAP-Exatecan)

    GLOBENEWSWIRE

    Avacta Announces Year-End Trading Update

    GLOBENEWSWIRE

    AVA6000 Phase 1b Trial Shows Tumor Shrinkage in Salivary Cancers

    GLOBENEWSWIRE

    Avacta Unveils Strong Phase 1A Results For Faridoxorubicin

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.